Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/1996
03/06/1996EP0699753A2 Protein for the transport of cationic xenobiotic and/or pharmaceutical compounds, DNA sequences coding therefore and its uses
03/06/1996EP0699688A2 Chlamydia pneumoniae specific monoclonal antibodies and their diagnostic use
03/06/1996EP0699306A1 Assay for cardiac troponin i
03/06/1996EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof
03/06/1996EP0699079A1 Bioactive and/or targeted dendrimer conjugates
03/06/1996EP0699078A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins
03/06/1996EP0699077A1 Hiv immunogenic complexes
03/06/1996EP0699076A1 Otitis media vaccine
03/06/1996EP0652769B1 Vaccines against metazoan parasites
03/06/1996EP0479899B1 Vasodilatory and immune suppressant peptides
03/06/1996EP0476059B1 Methods for enhancing the rate of modification of metastable bonds
03/06/1996EP0395653B1 Synovial phospholipases
03/06/1996EP0387319B1 Secretory leader sequences
03/06/1996EP0362259B1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method
03/06/1996EP0315637B1 Polypeptides useful in diagnosis of mycoplasma infections in swine and recombinant-dna methods for manufacturing same
03/06/1996CN1118008A Erythropoietin for human
03/06/1996CN1117873A Usage of follicle-stimulating hormone
03/05/1996US5496934 Nucleic acids encoding a cellulose binding domain
03/05/1996US5496802 Protein; antibody
03/05/1996US5496731 Anti-oncogenes
03/05/1996US5496724 Genes encoding platelet aggregation inhibitors
03/05/1996US5496721 Methods of generating desired amino-terminal residues in proteins
03/05/1996US5496706 Methods and materials for the detection of Staphylococcus aureus
03/05/1996US5496705 Monoclonal antibody specific for rat synaptophysin
03/05/1996US5496549 Bispecific monoclonal antibodies, thrombolytic agent and method of cell lysis
03/05/1996CA2012264C Anti-human sperm antibody and its production and use
03/05/1996CA1338122C Tissue factor inhibitor of coagulation
02/1996
02/29/1996WO1996006188A1 Peptide librairies as a source of syngenes
02/29/1996WO1996006174A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES
02/29/1996WO1996006171A2 New polypetides having a toxic activity against insects of the dipterae family
02/29/1996WO1996006170A1 Method of treating birds with avian myelomonocytic growth factor
02/29/1996WO1996006169A1 Human chemokine beta-9
02/29/1996WO1996006168A2 Retinoblastoma protein-interacting zinc finger proteins
02/29/1996WO1996006167A1 Glutamate receptor
02/29/1996WO1996006159A1 Unique associated kaposi's sarcoma virus sequences and uses thereof
02/29/1996WO1996006113A1 New immunocontraceptive peptides
02/29/1996WO1996006112A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection
02/29/1996WO1996005859A1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
02/29/1996WO1996005858A1 Haemophilus adherence and penetration proteins
02/29/1996WO1996005856A1 Human chemokine polypeptides
02/29/1996WO1996005847A1 A method of sequencing proteins by epitope ordering and protein restriction mapping
02/29/1996CA2198279A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection
02/29/1996CA2198265A1 New immunocontraceptive peptides
02/29/1996CA2198206A1 Human chemokine beta-9
02/29/1996CA2197890A1 Retinoblastoma protein-interacting zinc finger proteins
02/29/1996CA2197864A1 Peptide libraries as a source of syngenes
02/29/1996CA2197650A1 Method of treating birds with avian myelomonocytic growth factor
02/29/1996CA2197562A1 Haemophilus adherence and penetration proteins
02/29/1996CA2197493A1 A method of sequencing proteins by epitope ordering and protein restriction mapping
02/29/1996CA2196997A1 Glutamate receptor
02/29/1996CA2196892A1 Unique associated kaposi's sarcoma virus sequences and uses thereof
02/28/1996EP0698117A1 Monoclonal antibodies against ck-mb
02/28/1996EP0698116A1 Processes for producing an enzyme
02/28/1996EP0698115A1 Methods and compositions relating to sterol regulatory element binding proteins
02/28/1996EP0698107A1 Gene therapy for haemophilia
02/28/1996EP0698105A1 Nucleotide sequences for the control of the expression of dna sequences in a cellular host
02/28/1996EP0698104A1 Hippuricase gene
02/28/1996EP0698103A1 CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE
02/28/1996EP0698101A1 Hepatitis-c virus type 4, 5 and 6
02/28/1996EP0698099A1 Method for the culture in vitro of differents stages of tissue parasites
02/28/1996EP0698097A1 PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
02/28/1996EP0698095A1 Bmp-10 compositions
02/28/1996EP0698094A1 Bmp-11 compositions
02/28/1996EP0698093A1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE
02/28/1996EP0698092A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same
02/28/1996EP0698089A1 Nucleic acid encoding amp-activated protein kinase
02/28/1996EP0698086A1 Yeast strain and methods for expressing heterologous proteins in yeast
02/28/1996EP0698042A1 Composition of antibodies against hepatitis b surface antigen
02/28/1996EP0698037A1 Separation of anti-metal chelate antibodies
02/28/1996EP0697893A1 Neural thread protein gene expression and detection of alzheimer's disease
02/28/1996EP0697889A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
02/28/1996EP0697888A1 Conserved motif of hepatitis c virus e2/ns1 region
02/28/1996EP0697880A1 Inhibition of leukocyte adhesion
02/28/1996EP0697857A1 Hookworm anticoagulant
02/28/1996EP0511967B1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies
02/28/1996EP0362367B1 Osteogenic devices
02/28/1996CN1117526A Recombinant single chain Fv antibody fragment and its use in the immunopurification of the recombinant hepatitus B virus surface antigen
02/27/1996US5495071 Genetic engineering
02/27/1996US5495002 Tumor associated monoclonal antibody 123AV16
02/27/1996US5494999 For assaying, purifying or inducing cdw52 antibody
02/27/1996US5494818 A fusion protein encoded by the dna which specifically cleaves in vitro between c-terminal residue of ubiquitin and n-terminal residue of protein
02/27/1996US5494809 Culturing and incubating cells of bacillus amyloliquefaciens
02/27/1996US5494807 NYVAC vaccinia virus recombinants comprising heterologous inserts
02/27/1996US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence
02/27/1996US5494802 Tissue antigen and diagnostic method for human osteoporosis using the same
02/27/1996US5494792 Kainate-binding, human CNS receptors of the EAA2 family
02/27/1996US5494791 Monoclonal antibodies against glycated low density lipoprotein
02/27/1996US5494672 Pseudomonas peptide composition and method
02/24/1996WO1996006181A1 Method of modifying protein
02/22/1996WO1996005314A2 Protein toxins active against lepidopteran pests
02/22/1996WO1996005313A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG
02/22/1996WO1996005312A1 Novel trypanosoma cruzi antigen, and gene coding therefor; their application to the detection of chagas' disease
02/22/1996WO1996005306A2 IN VIVO MUTATIONS AND POLYMORPHISMS IN THE 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE
02/22/1996WO1996005301A1 Novel vesicular acetylcholine carrier
02/22/1996WO1996005300A2 Or-1 on orphan receptor belonging to the nuclear receptor family
02/22/1996WO1996005292A1 Antigenically-marked non-infectious retrovirus-like particles
02/22/1996WO1996005291A1 Recombinant herpesvirus of turkeys and uses thereof
02/22/1996WO1996005232A1 Apoptosis related protein bcl-y, and methods of use thereof
02/22/1996WO1996005230A1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA
02/22/1996WO1996005229A1 Human-murine chimeric antibodies against respiratory syncytial virus